Delivery Order SPE2DB22D2206-SPE2DB25FHV19
Award Date 7/9/25
Potential Completion Date 7/30/25
Potential Value $7.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $14,406.80 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XOLAIR 150 MG/ML SYRINGEML, a prescription pharmaceutical product, with a performance period through July 8, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC)...
- This is a $1,440.70 firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The order is for XOLAIR 150 MG/ML SYRINGEML, a medical product, with a completion date of July 15, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive global...
- This is a $36,017.00 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of XOLAIR 150 MG/ML SYRINGE/ML, a prescription medication. The contract has an ultimate completion date of July 25, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
- This is a $8,440.40 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XOLAIR 150 MG/ML SYRINGEML, a pharmaceutical product, with an ultimate completion date of June 11, 2025. The contract is not designated as a set-aside, indicating open competition. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $27,012.90 contract is for the delivery of XOLAIR 150 MG/ML syringes, a medication used to treat certain respiratory conditions. The contract has an ultimate completion date of July 15, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XOLAIR 150 MG/ML SYRINGEML, a medication, with a ceiling value of $10,805.16 and an ultimate completion date of August 6, 2025. The contract was competitively awarded and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of XOLAIR 150 MG/ML SYRINGE syringes. The contract has a firm fixed price of $2,881.36 and a completion date of July 16, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which enables AmerisourceBergen Drug Corp to supply a wide range of...
- This is a $21,610.20 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XOLAIR 150 MG/ML SYRINGEML, a pharmaceutical product, with a performance period ending on July 18, 2025. The contract is not set aside for any small business categories. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,440.70 fixed-price contract is for the delivery of XOLAIR 150 MG/ML SYRINGEML, a pharmaceutical product, with a completion date of July 23, 2025. The contract is not designated as a set-aside and represents an open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
- This is a $4,322.08 firm fixed-price delivery order contract awarded by the Defense Logistics Agency to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of XOLAIR 150 MG/ML SYRINGE, a pharmaceutical product, with a period of performance through July 24, 2025. The contract is not set aside and was awarded through open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...